Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy

Molecular and Cellular Biochemistry

Volumn 245, Issue 1-2, 2003, Pages 183-190

  Sangaralingham, S Jeson ^a   Pak, Brian J ^a   Tse, M Yat ^a   Angelis, Ekaterini ^a   Adams, Michael A ^a   Smallegange, C ^a   Pang, Stephen C ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Cardiac hypertrophy; Experimental hypertension; Gene expression; NAT1; Translational repressor

Indexed keywords

CYTIDINE DEAMINASE; MESSENGER RNA; PROTEIN NAT1; REPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME SUBSTRATE; EXPERIMENTAL MODEL; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; MALE; MOLECULAR SIZE; NONHUMAN; NORTHERN BLOTTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; REVIEW; RNA TRANSLATION; SPONTANEOUSLY HYPERTENSIVE RAT; STOP CODON; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACETYLTRANSFERASES; ANGIOTENSIN II; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BODY WEIGHT; CARDIOMEGALY; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEART VENTRICLES; HYPERTENSION; ISOENZYMES; MALE; MOLECULAR WEIGHT; ORGAN SIZE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; RNA PROCESSING, POST-TRANSCRIPTIONAL;

ANIMALIA;

EID: 0037359233     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022884515544     Document Type: Review

References (32)

1. Imamura T, McDermott PJ, Kent RL, Nagatsu M, Cooper G, Carabello BA: Acute changes in myosin heavy chain synthesis rate in pressure vs. volume overload. Circ Res 75: 418-425, 1994
2. Mezzetti G, Ferrari S, Davalli P, Battini R, Corti A: Peptide chain initiation and analysis of in vitro translation products in rat heart undergoing hypertrophic growth. J Mol Cell Cardiol 15: 629-635, 1983
3. Nagai R, Low RB, Stirewalt WS, Alpert NR, Litten RZ: Efficiency and capacity of protein synthesis are increased in pressure overload cardiac hypertrophy. Am J Physiol 255: H325-H328, 1988
4. Parmacek MS, Magid NM, Lesch M, Decker RS, Samarel AM: Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy. Am J Physiol 251: C727-C736, 1986
5. Everett AW, Sparrow MP, Taylor RR: Early changes in myocardial protein synthesis in vivo in response to right ventricular pressure overload in the dog. J Mol Cell Cardiol 11: 1253-1263, 1979
6. Mader S, Sonenberg N: Cap binding complexes and cellular growth control. Biochimie 77: 40-44, 1995
7. Polunovsky VA, Rosenwald IB, Tan AT, White J, Chiang L, Sonenberg N, Bitterman PB: Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc. Mol Cell Biol 16:6 573-6581, 1996
8. Sonenberg N: Regulation of translation and cell growth by eIF-4E. Biochimie 76: 839-846, 1994
9. Merrick WC: Mechanism and regulation of eukaryotic protein synthesis. Microbiol Rev 56: 291-315, 1992
10. Imataka H, Olsen HS, Sonenberg N: A new translational regulator with homology to eukaryotic translation initiation factor 4G. EMBO J 16: 817-825, 1997
11. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, Sonenberg N: Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10: 1134-1144, 1990
12. Lamphear BJ, Kirchweger R, Skern T, Rhoads RE: Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation. J Biol Chem 270: 21975-21983, 1995
13. Pelletier J, Kaplan G, Racaniello VR, Sonenberg N: Cap-independent translation of poliovirus mRNA is conferred by sequence elements within the 5′ noncoding region. Mol Cell Biol 8: 1103-1112, 1988
14. Yamanaka S, Poksay KS, Arnold KS, Innerarity TL: A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA- editing enzyme. Genes Dev 11: 321-333, 1997
15. Levy-Strumpf N, Deiss LP, Berissi H, Kimchi A: DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death. Mol Cell Biol 17: 1615-1625, 1997
16. Imataka H, Sonenberg N: Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A. Mol Cell Biol 17: 6940-6947, 1997
17. Chen SH, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, Silberman SR, Cai SJ, Deslypere JP, Rosseneu M, Gotto, JM Jr, Li WH, Chan L: Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238: 363-366, 1987
18. Liao W, Hong SH, Chan BH, Rudolph FB, Clark SC, Chan L: APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun 260: 398-404, 1999
19. Pak BJ, Pang SC: Developmental regulation of the translational repressor NAT1 during cardiac development. J Mol Cell Cardiol 31: 1717-1724, 1999
20. Yamanaka S, Zhang XY, Maeda M, Miura K, Wang S, Farese RV Jr, Iwao H, Innerarity TL: Essential role of NAT1/p97/DAP5 in embryonic differentiation and the retinoic acid pathway. EMBO J 19: 5533-5541, 2000
21. Wickman A, Friberg P, Adams MA, Matejka GL, Brantsing C, Guron G, Isgaard J: Induction of growth hormone receptor and insulin-like growth factor-I mRNA in aorta and caval vein during hemodynamic challenge. Hypertension 29: 123-130, 1997
22. Dool JS, Mak AS, Friberg P, Wahlander H, Hawrylechko A, Adams MA: Regional myosin heavy chain expression in volume and pressure overload induced cardiac hypertrophy. Acta Physiol Scand 155: 396-404, 1995
23. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537, 1993
24. Sambrooke J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York, 1989
25. Peterson GL: A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356, 1977
26. Mamuya W, Chobanian A, Brecher P: Age-related changes in fibronectin expression in spontaneously hypertensive, Wistar-Kyoto, and Wistar rat hearts. Circ Res 71: 1341-1350, 1992
27. Brilla CG, Maisch B, Weber KT: Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: In vivo and in vitro studies on collagen matrix regulation. Clin Invest 71: S35-S41, 1993
28. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865, 1991
29. Clarke K, Ward LC: Protein synthesis in the early stages of cardiac hypertrophy. Int J Biochem 15: 1267-1271, 1983
30. Sunga PS, Rabkin SW: Angiotensin II-induced protein phosphorylation in the hypertrophic heart of the Dahl rat. Hypertension 20: 633-642, 1992
31. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, Yokoyama M: Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 272: 16018-16022, 1997
32. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J: A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell 50: 831-840, 1987